In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...

I must say, I'm impressed by all of your eagerness to share the little quibbles you have your cars.

Over the past decade, InnoCare has achieved remarkable results. 2026 marks the beginning of the Company’s next golden decade of development. Driven by its outstanding performance in 2025, the Company ...

Germany had opened applications for a fully funded SLE programme at Humboldt University, offering scholarships and training ...

A surge in wildfire incidents across the UK has prompted fresh scrutiny from MPs, as rural leaders warn the threat is ...

Cartesian Therapeutics' lead asset, Descartes-08, demonstrated a 7.1-point MG-ADL reduction at 12 months in Phase 2b. Find ...

Clinic-level interventions increased reproductive health counseling rates for women with systemic autoimmune diseases.

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...

RHHBY's Gazyva gets FDA review for lupus as strong trial data and pipeline wins across neurology and MS bolster growth outlook.

US FDA accepts Roche’s sBLA for Gazyva/Gazyvaro for the treatment of systemic lupus erythematosus: Basel Wednesday, April 22, 2026, 09:00 Hrs [IST] Roche announced that the US F ...

Ursuline Secondary School trio Ruth O’Connell, Aislinn Smee and Isabel Ralph won the TG4 Slé Anois go Cúramach quiz recently.